Roman Dziarski Selected Research

peptidoglycan recognition protein

12/2019	The Pglyrp1-Regulated Microbiome Enhances Experimental Allergic Asthma.
9/2014	Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis.
4/2013	Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses.
1/2013	Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease.
6/2012	Mammalian peptidoglycan recognition proteins kill bacteria by activating two-component systems and modulate microbiome and inflammation.
12/2011	Peptidoglycan recognition protein Pglyrp2 protects mice from psoriasis-like skin inflammation by promoting regulatory T cells and limiting Th17 responses.
11/2011	Peptidoglycan recognition proteins: modulators of the microbiome and inflammation.
1/2011	Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells.
8/2010	Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
6/2010	Review: Mammalian peptidoglycan recognition proteins (PGRPs) in innate immunity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roman Dziarski Research Topics

Disease

8	Inflammation (Inflammations) 11/2020 - 01/2008
5	Infections 09/2007 - 07/2003
3	Colitis 01/2016 - 08/2010
2	Asthma (Bronchial Asthma) 12/2019 - 04/2013
2	Hyperplasia 04/2013 - 08/2010
2	Bacterial Infections (Bacterial Infection) 09/2009 - 09/2007
1	Neoplasms (Cancer) 11/2020
1	Obesity 11/2020
1	Carcinogenesis 11/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Weight Gain 01/2017
1	Body Weight (Weight, Body) 09/2014
1	Hemorrhage 09/2014
1	Fibrosis (Cirrhosis) 04/2013
1	Hypertrophy 04/2013
1	Metaplasia 04/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2011
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Atopic Dermatitis (Atopic Eczema) 01/2011
1	Keratitis 09/2009
1	Arthritis (Polyarthritis) 02/2009
1	Brain Ischemia (Cerebral Ischemia) 01/2008

Drug/Important Bio-Agent (IBA)

13	peptidoglycan recognition proteinIBA 12/2019 - 07/2003
5	Peptidoglycan (Murein)IBA 01/2020 - 01/2006
5	Proteins (Proteins, Gene)FDA Link 09/2014 - 09/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 01/2016
2	Dextran SulfateIBA 01/2016 - 08/2010
2	ChemokinesIBA 09/2014 - 02/2009
2	Interleukin-17 (Interleukin 17)IBA 04/2013 - 01/2011
2	AllergensIBA 04/2013 - 01/2011
1	SteroidsIBA 11/2020
1	CholesterolIBA 11/2020
1	Pattern Recognition ReceptorsIBA 11/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2014
1	Dextrans (Dextran)FDA Link 09/2014
1	CytokinesIBA 09/2014
1	Adenosine Triphosphate (ATP)IBA 09/2014
1	Immunoglobulin E (IgE)IBA 04/2013
1	MucinsIBA 04/2013
1	Interleukin-4 (Interleukin 4)IBA 04/2013
1	Interleukin-5 (Interleukin 5)IBA 04/2013
1	OxazoloneIBA 01/2011
1	Vitamin D FDA LinkGeneric 01/2011
1	InterferonsIBA 08/2010
1	Interferon-gamma (Interferon, gamma)IBA 08/2010
1	NF-kappa B (NF-kB)IBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 01/2008
1	AmidohydrolasesIBA 09/2007
1	Antimicrobial PeptidesIBA 03/2006